AU2007237116B2 - Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites - Google Patents

Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites Download PDF

Info

Publication number
AU2007237116B2
AU2007237116B2 AU2007237116A AU2007237116A AU2007237116B2 AU 2007237116 B2 AU2007237116 B2 AU 2007237116B2 AU 2007237116 A AU2007237116 A AU 2007237116A AU 2007237116 A AU2007237116 A AU 2007237116A AU 2007237116 B2 AU2007237116 B2 AU 2007237116B2
Authority
AU
Australia
Prior art keywords
stent
bath
polymeric stent
solvent
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007237116A
Other languages
English (en)
Other versions
AU2007237116A1 (en
Inventor
Patrick Sabaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sahajanand Medical Technologies Ltd
Original Assignee
Sahajanand Medical Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahajanand Medical Technologies Ltd filed Critical Sahajanand Medical Technologies Ltd
Publication of AU2007237116A1 publication Critical patent/AU2007237116A1/en
Application granted granted Critical
Publication of AU2007237116B2 publication Critical patent/AU2007237116B2/en
Assigned to SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED reassignment SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED Request for Assignment Assignors: ARTERIAL REMODELING TECHNOLOGIES, S.A.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AU2007237116A 2006-04-12 2007-04-11 Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites Ceased AU2007237116B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79122006P 2006-04-12 2006-04-12
US60/791,220 2006-04-12
US81453306P 2006-06-19 2006-06-19
US60/814,533 2006-06-19
US85407506P 2006-10-25 2006-10-25
US60/854,075 2006-10-25
PCT/IB2007/000941 WO2007116305A2 (en) 2006-04-12 2007-04-11 Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites

Publications (2)

Publication Number Publication Date
AU2007237116A1 AU2007237116A1 (en) 2007-10-18
AU2007237116B2 true AU2007237116B2 (en) 2012-09-27

Family

ID=38352507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007237116A Ceased AU2007237116B2 (en) 2006-04-12 2007-04-11 Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites

Country Status (9)

Country Link
US (1) US9078957B2 (enExample)
EP (1) EP2004104B1 (enExample)
JP (1) JP5201635B2 (enExample)
AT (1) ATE543467T1 (enExample)
AU (1) AU2007237116B2 (enExample)
BR (1) BRPI0710137B8 (enExample)
CA (1) CA2645357C (enExample)
ES (1) ES2381701T3 (enExample)
WO (1) WO2007116305A2 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003002243A2 (en) 2001-06-27 2003-01-09 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20070286941A1 (en) 2006-06-13 2007-12-13 Bin Huang Surface treatment of a polymeric stent
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
CA2659761A1 (en) 2006-08-02 2008-02-07 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
JP2010503494A (ja) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド 生分解性内部人工器官およびその製造方法
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
DE602007011114D1 (de) * 2006-09-15 2011-01-20 Boston Scient Scimed Inc Biologisch erodierbare endoprothese mit biostabilen anorganischen schichten
CA2663250A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
CA2663762A1 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
CA2674195A1 (en) 2006-12-28 2008-07-10 Boston Scientific Limited Bioerodible endoprostheses and methods of making same
US20130150943A1 (en) 2007-01-19 2013-06-13 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8128983B2 (en) * 2008-04-11 2012-03-06 Abbott Cardiovascular Systems Inc. Coating comprising poly(ethylene glycol)-poly(lactide-glycolide-caprolactone) interpenetrating network
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8267992B2 (en) 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8568471B2 (en) 2010-01-30 2013-10-29 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
WO2011119573A1 (en) 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8844113B2 (en) * 2010-04-30 2014-09-30 Abbott Cardiovascular Systems, Inc. Methods for crimping a polymeric stent scaffold onto a delivery balloon
US8261423B2 (en) 2010-04-30 2012-09-11 Abbott Cardiovascular Systems Inc. Methods for crimping a polymeric stent onto a delivery balloon
US9345602B2 (en) * 2010-09-23 2016-05-24 Abbott Cardiovascular Systems Inc. Processes for making crush recoverable polymer scaffolds
US8961848B2 (en) 2011-04-18 2015-02-24 Abbott Cardiovascular Systems Inc. Methods for increasing a retention force between a polymeric scaffold and a delivery balloon
WO2012145326A1 (en) * 2011-04-18 2012-10-26 Abbott Cardiovascular Systems Inc. Uniform crimping and deployment methods for polymer scaffold
US9724219B2 (en) 2012-10-04 2017-08-08 Abbott Cardiovascular Systems Inc. Method of uniform crimping and expansion of medical devices
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
EP3861961B1 (en) 2016-05-16 2025-11-12 Elixir Medical Corporation Uncaging stent
EP3474787A4 (en) * 2016-06-23 2020-02-19 Poly-Med, Inc. MEDICAL IMPLANTS WITH MANAGED BIODEGRADATION
US10660773B2 (en) 2017-02-14 2020-05-26 Abbott Cardiovascular Systems Inc. Crimping methods for thin-walled scaffolds
US10555825B2 (en) 2017-11-09 2020-02-11 Abbott Cardiovascular Systems Inc. Rotation of a medical device during crimping
US10967556B2 (en) 2018-06-11 2021-04-06 Abbott Cardiovascular Systems Inc. Uniform expansion of thin-walled scaffolds
JP7479661B2 (ja) * 2018-10-03 2024-05-09 国立大学法人秋田大学 抗血小板粘着性を示す生分解性共重合体

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761251A1 (en) * 1994-10-17 1997-03-12 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US20050187615A1 (en) * 2004-02-23 2005-08-25 Williams Michael S. Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture
WO2007106247A2 (en) * 2006-02-28 2007-09-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide)-based drug delivery systems with controlled release rate and morphology

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439003A1 (fr) * 1978-10-20 1980-05-16 Anvar Nouvelles pieces d'osteosynthese, leur preparation et leur application
US5957975A (en) * 1997-12-15 1999-09-28 The Cleveland Clinic Foundation Stent having a programmed pattern of in vivo degradation
US20040180131A1 (en) * 2003-03-14 2004-09-16 Medtronic Ave. Stent coating method
US9283099B2 (en) * 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761251A1 (en) * 1994-10-17 1997-03-12 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US20050187615A1 (en) * 2004-02-23 2005-08-25 Williams Michael S. Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture
WO2007106247A2 (en) * 2006-02-28 2007-09-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide)-based drug delivery systems with controlled release rate and morphology

Also Published As

Publication number Publication date
BRPI0710137B8 (pt) 2021-06-22
CA2645357A1 (en) 2007-10-18
US20090095715A1 (en) 2009-04-16
ES2381701T3 (es) 2012-05-30
JP5201635B2 (ja) 2013-06-05
EP2004104A2 (en) 2008-12-24
WO2007116305A2 (en) 2007-10-18
EP2004104B1 (en) 2012-02-01
JP2009542263A (ja) 2009-12-03
AU2007237116A1 (en) 2007-10-18
ATE543467T1 (de) 2012-02-15
WO2007116305A3 (en) 2008-07-31
BRPI0710137B1 (pt) 2019-04-24
US9078957B2 (en) 2015-07-14
BRPI0710137A2 (pt) 2011-08-09
CA2645357C (en) 2016-02-16

Similar Documents

Publication Publication Date Title
AU2007237116B2 (en) Improved methods of polymeric stent surface smoothing and resurfacing to reduce biologically active sites
US9326869B2 (en) Method for expansion and development of polymeric structures including stents
US20090105800A1 (en) Methods of minimizing stent contraction following deployment
AU2004318159B8 (en) Polymer-based stent assembly
US20090133817A1 (en) Stent manufacturing methods
CN101437471B (zh) 使聚合物支架表面光滑和重修表面以减少生物学活性部位的改进方法
JP5282069B2 (ja) ポリマーベースのステントアセンブリ
JP2018512201A (ja) 光活性基を有する生体内分解性ポリマー系医療用デバイス
JP5675756B2 (ja) ポリマーベースのステントアセンブリ
HK1102420B (en) Polymer-based stent assembly
JP2013046829A (ja) ポリマーベースのステントアセンブリ

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTORS TO ADD TAHMER, SHARKAWI

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ SABARIA, PATRICK

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SAHAJANAND MEDICAL TECHNOLOGIES PRIVATE LIMITED

Free format text: FORMER OWNER(S): ARTERIAL REMODELING TECHNOLOGIES, S.A.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired